- All sections
- G - Physics
- G01N - Investigating or analysing materials by determining their chemical or physical properties
- G01N 33/563 - Immunoassay; Biospecific binding assay; Materials therefor involving antibody fragments
Patent holdings for IPC class G01N 33/563
Total number of patents in this class: 394
10-year publication summary
|
7
|
10
|
19
|
18
|
25
|
38
|
45
|
28
|
36
|
13
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| The Regents of the University of California | 18943 |
8 |
| ARK Diagnostics, Inc. | 30 |
8 |
| IDEXX Laboratories, Inc. | 730 |
4 |
| InBios International, Inc. | 32 |
4 |
| Redcoat Solutions, Inc. | 11 |
4 |
| Hoffmann-La Roche Inc. | 3060 |
3 |
| Becton, Dickinson and Company | 6712 |
3 |
| Agilent Technologies, Inc. | 2744 |
3 |
| Board of Regents, The University of Texas System | 5370 |
3 |
| The Johns Hopkins University | 5377 |
3 |
| Agency for Science, Technology and Research | 3512 |
3 |
| The Brigham and Women's Hospital, Inc. | 2087 |
3 |
| Immunovia AB | 43 |
3 |
| Kookmin University Industry Academy Cooperation Foundation | 337 |
3 |
| Nour Heart, Inc. | 18 |
3 |
| Regeneron Pharmaceuticals, Inc. | 3650 |
3 |
| The Rockefeller University | 562 |
3 |
| SRI International | 974 |
3 |
| Temasek Life Sciences Laboratory Limited | 139 |
3 |
| University Health Network | 979 |
3 |
| Other owners | 321 |